SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-21-002047
Filing Date
2021-03-05
Accepted
2021-03-05 20:54:43
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 5  
1 PRIMARY DOCUMENT primarydocument.xml 5 4140
  Complete submission text file 0001562180-21-002047.txt   5516
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Conway Charles (Reporting) CIK: 0001704256 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38080 | Film No.: 21720403